KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Non-Current Assets (2016 - 2026)

HCA Healthcare (HCA) has disclosed Non-Current Assets for 17 consecutive years, with $45.4 billion as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 4.27% year-over-year to $45.4 billion; the TTM value through Mar 2026 reached $178.8 billion, up 4.15%, while the annual FY2025 figure was $44.9 billion, 4.26% up from the prior year.
  • Non-Current Assets hit $45.4 billion in Q1 2026 for HCA Healthcare, up from $44.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $45.4 billion in Q1 2026 and bottomed at $37.2 billion in Q1 2022.
  • Average Non-Current Assets over 5 years is $41.4 billion, with a median of $41.7 billion recorded in 2024.
  • Year-over-year, Non-Current Assets rose 6.42% in 2023 and then increased 3.89% in 2025.
  • HCA Healthcare's Non-Current Assets stood at $38.8 billion in 2022, then rose by 6.42% to $41.3 billion in 2023, then increased by 4.4% to $43.1 billion in 2024, then grew by 4.26% to $44.9 billion in 2025, then grew by 1.03% to $45.4 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $45.4 billion, $44.9 billion, and $44.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.